ArticleBMC cancer2026

The radiosensitizing effects of a STAT3/HDAC dual-target inhibitor derived from isoalantolactone in solid tumor models.

Qi Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.